Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: 13G is out

From last years 13G...

posted on Feb 14, 2008 08:41AM

Swartz/Lincoln controlled 38,092,451 shares or 9.99% of the total.

Compared to the present 23,737,829 or 6.1%...

a difference of 14,354,622 painful shares.

Go PTSC Onwards and Upwards!

Cheers~

Share
New Message
Please login to post a reply